Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine

Aust J Gen Pract. 2020 Apr 8;49. doi: 10.31128/AJGP-COVID-06. Online ahead of print.

Abstract

There is currently no robust evidence to support prescribing hydroxychloroquine as a treatment or prophylaxis for COVID-19.